How does NAN's PE Ratio compare to its peers?

NAN is expensive based on its Price-To-Earnings Ratio (76.5x) compared to the peer average (40.4x).

How does NAN's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

NAN is expensive based on its Price-To-Earnings Ratio (76.5x) compared to the Global Medical Equipment industry average (28.5x).

What is NAN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NAN is expensive based on its Price-To-Earnings Ratio (76.5x) compared to the estimated Fair Price-To-Earnings Ratio (39.7x).

What is the Fair Price of NAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

NAN (A$3.27) is trading below our estimate of [[fair value]] (A$5.01)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

Nanosonics (ASX:NAN) - Stock Price, News & Analysis

NAN Stock Overview

Operates as an infection prevention company globally. More details

NAN fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 34.7% below our estimate of its fair value

Earnings are forecast to grow 23.96% per year

Risk Analysis

Profit margins (7.6%) are lower than last year (12%)

Nanosonics Limited Competitors

SDI

ASX:SDI

AU$132.5m

Ansell

ASX:ANN

AU$4.8b

Paragon Care

ASX:PGC

AU$819.4m

Australian Clinical Labs

ASX:ACL

AU$689.5m

Price History & Performance

Summary of all time highs, changes and price drops for Nanosonics
Historical stock prices
Current Share Price	AU$3.27
52 Week High	AU$4.76
52 Week Low	AU$2.59
Beta	1.57
11 Month Change	2.19%
3 Month Change	-4.94%
1 Year Change	-23.24%
33 Year Change	-41.19%
5 Year Change	-49.30%
Change since IPO	298.78%

Nanosonics (ASX:NAN) Is Reinvesting At Lower Rates Of Return

Nov 28

Nanosonics Limited's (ASX:NAN) Shares Climb 29% But Its Business Is Yet to Catch Up

Sep 18

Recent updates

Nanosonics (ASX:NAN) Is Reinvesting At Lower Rates Of Return

Nov 28

Nanosonics Limited's (ASX:NAN) Shares Climb 29% But Its Business Is Yet to Catch Up

Sep 18

An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued

Mar 30

Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)

Mar 15

Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook

Feb 28

Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Feb 19

Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?

Feb 07

What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?

Jan 26

How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?

Jan 14

Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative

Jan 01

Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)

Dec 20

Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?

Dec 07

Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?

Nov 25

Shareholder Returns

	NAN	AU Medical Equipment	AU Market
7D	1.6%	1.0%	0.5%
1Y	-23.2%	12.2%	17.4%

Return vs Industry: NAN underperformed the Australian Medical Equipment industry which returned 12.2% over the past year.

Return vs Market: NAN underperformed the Australian Market which returned 17.4% over the past year.

Price Volatility

Is NAN's price volatile compared to industry and market?
NAN volatility
NAN Average Weekly Movement	4.7%
Medical Equipment Industry Average Movement	8.7%
Market Average Movement	8.3%
10% most volatile stocks in AU Market	17.0%
10% least volatile stocks in AU Market	3.2%

Stable Share Price: NAN has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: NAN's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2000	466	Michael Kavanagh	www.nanosonics.com.au

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.

Nanosonics Limited Fundamentals Summary

How do Nanosonics's earnings and revenue compare to its market cap?
NAN fundamental statistics
Market cap	AU$976.84m
Earnings (TTM)	AU$12.97m
Revenue (TTM)	AU$170.01m

76.5x

P/E Ratio

5.8x

P/S Ratio

Is NAN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NAN income statement (TTM)
Revenue	AU$170.01m
Cost of Revenue	AU$37.58m
Gross Profit	AU$132.44m
Other Expenses	AU$119.47m
Earnings	AU$12.97m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.043
Gross Margin	77.90%
Net Profit Margin	7.63%
Debt/Equity Ratio	0%

How did NAN perform over the long term?

See historical performance and comparison

NAN Stock Overview

Rewards

Risk Analysis

Nanosonics Limited Competitors

ASX:SDI

AU$132.5m

ASX:ANN

AU$4.8b

ASX:PGC

AU$819.4m

ASX:ACL

AU$689.5m

Price History & Performance

Recent News & Updates

Nanosonics (ASX:NAN) Is Reinvesting At Lower Rates Of Return

Nanosonics Limited Announces Board Retirements

Nanosonics Limited, Annual General Meeting, Nov 12, 2024

Nanosonics Limited's (ASX:NAN) Shares Climb 29% But Its Business Is Yet to Catch Up

New minor risk - Profit margin trend

Full year 2024 earnings: EPS exceeds analyst expectations

Recent updates

Nanosonics (ASX:NAN) Is Reinvesting At Lower Rates Of Return

Nanosonics Limited Announces Board Retirements

Nanosonics Limited, Annual General Meeting, Nov 12, 2024

Nanosonics Limited's (ASX:NAN) Shares Climb 29% But Its Business Is Yet to Catch Up

New minor risk - Profit margin trend

Full year 2024 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 19%

Nanosonics Limited to Report Fiscal Year 2024 Results on Aug 27, 2024

Independent Non-Executive Director recently sold AU$304k worth of stock

New minor risk - Insider selling

Key Executive recently bought AU$100k worth of stock

Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture

First half 2024 earnings released: EPS: AU$0.02 (vs AU$0.034 in 1H 2023)

Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%

Now 37% undervalued after recent price drop

Consensus EPS estimates fall by 15%

Nanosonics Limited to Report First Half, 2024 Results on Feb 26, 2024

Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?

Now 20% undervalued after recent price drop

Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist

Now 20% undervalued after recent price drop

Nanosonics Limited Announces Appointment of Jason Burriss as Chief Financial Officer, Effective 3 October 2023

Consensus EPS estimates fall by 22%, revenue upgraded

Nanosonics Limited Appoints Larry Marshall as Non- Executive Director, Effective from 3 October 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Nanosonics Limited, Annual General Meeting, Nov 03, 2023

Nanosonics Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Nanosonics Limited Announces the Appointment of Tracey Batten as Non-Executive Director, Effective 26 September 2023

Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?

CEO, President recently sold AU$121k worth of stock

Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around

Nanosonics Announces Company Secretary Changes

Independent Non-Executive Director recently sold AU$504k worth of stock

First half 2023 earnings: Revenues in line with analyst expectations

Consensus EPS estimates increase by 16%

Nanosonics Limited to Report First Half, 2023 Results on Feb 23, 2023

Consensus EPS estimates increase by 11%

Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?

Consensus EPS estimates increase by 25%

Insufficient new directors

Insufficient new directors

This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate

A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)

What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?

Now 20% undervalued

CEO, President recently sold AU$960k worth of stock

Consensus forecasts updated

Full year 2022 earnings: EPS exceeds analyst expectations

Nanosonics Limited, Annual General Meeting, Nov 18, 2022

Nanosonics Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Insufficient new directors

Consensus estimates of losses per share improve by 40%

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)

Now 21% undervalued after recent price drop

At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?

Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends

Now 21% undervalued after recent price drop

Nanosonics Limited Announces Management Changes